1996
DOI: 10.1136/thx.51.3.298
|View full text |Cite|
|
Sign up to set email alerts
|

Cost of care of patients with cystic fibrosis in The Netherlands in 1990-1.

Abstract: Background -Research on the cost of care of patients with cystic fibrosis is scarce. The aim of this study was to estimate the costs using age-specific medical consumption from real patient data. Methods -The age-specific medical consumption ofpatients with cystic fibrosis in The Netherlands in 1991 was estimated from a survey of medical records and a patient questionnaire. A distinction was made between costs of hospital care, hospital and non-hospital medication, and home care. Costs per year were obtained b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
26
2
6

Year Published

1996
1996
2021
2021

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 48 publications
(35 citation statements)
references
References 5 publications
1
26
2
6
Order By: Relevance
“…Lifetime treatment costs are estimated to be lower in older studies, as prevention of progression (physiotherapy, high fat diet plus enzymes) and medications (IV therapy) were not yet universally applied. Over twenty years ago Wildhagen et al calculated Dutch lifetime costs per patient adjusting for survival and using a 5% discount rate to €287,591 (GBP 164,365 in 1991) (38), while later estimates in Germany based on extrapolation of childhood costs suggested €477,280 (€396,000 in 1997) (15) A c c e p t e d M a n u s c r i p t 13 between these estimates are primarily due to inclusion of only outpatient costs in Germany, while the American study incorporated direct costs including medication and inpatient care (though unclear whether outpatient costs were included).…”
Section: Cystic Fibrosismentioning
confidence: 99%
“…Lifetime treatment costs are estimated to be lower in older studies, as prevention of progression (physiotherapy, high fat diet plus enzymes) and medications (IV therapy) were not yet universally applied. Over twenty years ago Wildhagen et al calculated Dutch lifetime costs per patient adjusting for survival and using a 5% discount rate to €287,591 (GBP 164,365 in 1991) (38), while later estimates in Germany based on extrapolation of childhood costs suggested €477,280 (€396,000 in 1997) (15) A c c e p t e d M a n u s c r i p t 13 between these estimates are primarily due to inclusion of only outpatient costs in Germany, while the American study incorporated direct costs including medication and inpatient care (though unclear whether outpatient costs were included).…”
Section: Cystic Fibrosismentioning
confidence: 99%
“…The results of this analysis have been used in the calculation of the total costs of the disease cystic fibrosis [10]. For this reason, the medical consumption per age category was determined and the nonhospital costs added.…”
Section: Discussionmentioning
confidence: 99%
“…Several studies designed to assess the costs of illness in patients with CF were carried out more than two decades ago [13][14][15][16][17][18][19][20][21]. These studies were reviewed by Krauth et al [1] who highlighted the wide range of mean annual cost per patient (US $6,200-16,300, 1996 rate), mainly due to differences in the clinical conditions of the patients considered, healthcare systems involved, and in the completeness of healthcare services and resource consumed.…”
Section: Enhanced Content For Advances In Therapy Articles Is Availabmentioning
confidence: 99%
“…Most of these studies had major limitations, including the fact that only five were based on individual patient care data [14,16,[18][19][20], whereas three were only aggregated expert cost estimations.…”
Section: Enhanced Content For Advances In Therapy Articles Is Availabmentioning
confidence: 99%